| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SH2 domain containing 1A | 0.525 | 0.731 | 0.39 |
|
group | 0.520 | strong | 1.000 | 3 | 0 | 1999 | 2009 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 1996 | 2012 | ||||||||
|
X-linked inhibitor of apoptosis | 0.447 | 0.808 | 0.92 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
zeta chain of T cell receptor associated protein kinase 70 | 0.497 | 0.769 | 0.88 |
|
group | 0.130 | None | 1.000 | 3 | 0 | 2004 | 2018 | ||||||||
|
TNF receptor superfamily member 8 | 0.444 | 0.808 | 0.86 |
|
group | 0.100 | None | 0.986 | 72 | 0 | 1996 | 2020 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
group | 0.100 | None | 0.955 | 22 | 0 | 1987 | 2014 | |||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 2000 | 2019 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 2000 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 0.929 | 14 | 0 | 1990 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 1994 | 2004 | ||||||||
|
PDZ and LIM domain 7 | 0.474 | 0.808 | 0.71 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1995 | 2017 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1994 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.100 | None | 0.900 | 10 | 0 | 1993 | 2017 | ||||||||
|
interleukin 2 receptor subunit gamma | 0.535 | 0.769 | 0.99 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
minichromosome maintenance complex component 4 | 0.666 | 0.654 | 1.5E-04 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
CD70 molecule | 0.542 | 0.692 | 1.0E-02 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
phospholipase A2 activating protein | 0.597 | 0.692 | 0.47 |
|
group | 0.100 | None | 0 | 1 | |||||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
MYD88 innate immune signal transduction adaptor | 0.414 | 0.923 | 0.12 |
|
group | 0.080 | None | 0.875 | 8 | 1 | 2013 | 2019 | ||||||||
|
acyl-CoA synthetase bubblegum family member 1 | 0.603 | 0.654 | 4.0E-05 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1985 | 2020 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1996 | 2019 |